MaxCyte Inc's (LON:MXCT) Doug Doerfler speaks to investors at the Proactive One2One Virtual Event. They're a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. For more information visit www.maxcyte.com
10 Jul 20